Valued at USD 684.19 million in 2022, the AI in medical writing market is projected to reach USD 722.75 million in 2023 and USD 2,072.30 million by 2032, growing at a CAGR of 12.4% during the forecast period 2023–2032. According to Polaris Market Research, North America dominated in 2022 and Asia Pacific is the fastest-growing region.

For pharmaceutical companies, CROs and technology vendors, the AI in Medical Writing Market addresses the documentation burden created by clinical research and regulatory oversight. The report segments the market by type, end use and region.

Clinical Writing Is Expected to Grow Fastest

Clinical writing is expected to grow fastest among types, tied to rising clinical trial numbers and the need for accurate, well-structured clinical documentation. The report notes ClinicalTrials.gov listed around 454,928 actively recruiting studies as of March 2021. The type writing segment, as the report labels it, held the largest share in 2022, linked to scientific documentation, compiling clinical trial statistics for regulatory applications, and post-approval paperwork under strict compliance rules.

Regulatory Applications and FDA Clearance Requirements

Regulatory applications must be precise and concise. North America dominated in 2022, and Polaris highlights FDA clearance requirements that demand exactly this standard. Regulators including the FDA and EMA require extensive data to prove safety and efficacy, and U.S. clinical writing must meet FDA requirements. This regulatory intensity creates a strong case for tools that improve consistency and speed.

Natural Language Processing Automates Routine Work

Natural language processing algorithms automate the review of published literature, data extraction and summarization, reducing manual effort in document preparation. Polaris reports that some companies have cut medical writing time by 80%, and notes that large volumes of trial, preclinical and literature data are available to train AI models.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/ai-in-medical-writing-market

Safety Reports and Industry Collaboration

In June 2022, Sanofi, working with Yseop, an AI and NLP company,, aimed to automate safety reports. Yseop appears again in July 2024 in a strategic collaboration with Cognizant on scientific content development in biopharma. Such collaborations illustrate the competitive approach in the market, where players focus on partnerships, product upgrades and collaboration.

Segmentation, Drivers and Regional Coverage

The report segments the market by type, end use and region, with scientific writing and other types in addition to clinical writing and the largest-share type writing segment. A favorable environment for clinical studies in developing countries is cited as a driver, alongside stringent demands from bodies such as the FDA and EMA. North America is named the leading region in the report's FAQ. Country coverage includes the U.S. and Canada in North America; France, Germany, the UK, Italy, the Netherlands, Spain and Russia in Europe; Japan, China, India, Malaysia, Indonesia and South Korea in Asia Pacific; Brazil, Mexico and Argentina in Latin America; and Saudi Arabia, the UAE, Israel and South Africa in the Middle East & Africa.

The report was published in October 2023, with historical data for 2019 to 2021 and a forecast period of 2023 to 2032.

Market Constraints and Competitive Landscape

COVID-19 disrupted trials, delayed studies, cut pharma budgets and reduced journal submissions, though Polaris rates the impact as moderate. Data security and privacy issues are listed among restraints.

The AI in medical writing is consolidated, with limited players, and competition is expected to rise. Key players include Cactus Communications, Freyr, GENINVO, Parexel International and Trilogy Writing & Consulting. Polaris rates rivalry among existing firms as high, supplier power, buyer power and substitutes as moderate, and the threat of new entrants as low.

Outlook

Taken together, rising trial numbers, strict compliance rules and automation tools frame the demand outlook, with North America leading in 2022 and Asia Pacific the fastest-growing region, attributed to rising healthcare spending and AI advances in China, Japan, South Korea and India.

More Trending Latest Reports By Polaris Market Research:

electric-golf-carts-market

in-depth-overview-of-top-10-companies-in-cleanroom-technology-market

top-5-genomic-rwe-data-providers

kimchi-market

astaxanthin-market

metal-cans-market

agrochemicals-market

industrial-hemp-market

kitchen-appliances-market